Vanguard Group
MRNA icon

Vanguard Group’s Moderna MRNA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.15B Buy
41,708,705
+1,312,192
+3% +$36.2M 0.02% 626
2025
Q1
$1.15B Buy
40,396,513
+72,763
+0.2% +$2.06M 0.02% 602
2024
Q4
$1.68B Buy
40,323,750
+97,536
+0.2% +$4.06M 0.03% 512
2024
Q3
$2.69B Buy
40,226,214
+663,418
+2% +$44.3M 0.05% 376
2024
Q2
$4.7B Buy
39,562,796
+525,924
+1% +$62.5M 0.09% 200
2024
Q1
$4.16B Buy
39,036,872
+5,129,800
+15% +$547M 0.08% 246
2023
Q4
$3.37B Buy
33,907,072
+6,248,623
+23% +$621M 0.07% 281
2023
Q3
$2.86B Buy
27,658,449
+196,012
+0.7% +$20.2M 0.07% 289
2023
Q2
$3.34B Sell
27,462,437
-64,312
-0.2% -$7.81M 0.08% 255
2023
Q1
$4.23B Buy
27,526,749
+244,576
+0.9% +$37.6M 0.11% 179
2022
Q4
$4.9B Sell
27,282,173
-159,985
-0.6% -$28.7M 0.13% 145
2022
Q3
$3.25B Sell
27,442,158
-206,299
-0.7% -$24.4M 0.1% 215
2022
Q2
$3.95B Buy
27,648,457
+610,265
+2% +$87.2M 0.11% 179
2022
Q1
$4.66B Sell
27,038,192
-388,378
-1% -$66.9M 0.11% 174
2021
Q4
$6.97B Buy
27,426,570
+245,159
+0.9% +$62.3M 0.16% 106
2021
Q3
$10.5B Buy
27,181,411
+6,986,507
+35% +$2.69B 0.26% 64
2021
Q2
$4.75B Buy
20,194,904
+1,275,874
+7% +$300M 0.12% 147
2021
Q1
$2.48B Sell
18,919,030
-4,452,825
-19% -$583M 0.07% 326
2020
Q4
$2.44B Sell
23,371,855
-4,503,237
-16% -$470M 0.07% 299
2020
Q3
$1.97B Buy
27,875,092
+2,249,560
+9% +$159M 0.07% 312
2020
Q2
$1.65B Buy
25,625,532
+5,045,279
+25% +$324M 0.06% 348
2020
Q1
$616M Buy
20,580,253
+3,261,216
+19% +$97.7M 0.03% 595
2019
Q4
$339M Buy
17,319,037
+288,355
+2% +$5.64M 0.01% 1053
2019
Q3
$271M Buy
17,030,682
+16,606,498
+3,915% +$264M 0.01% 1149
2019
Q2
$6.21M Sell
424,184
-444,332
-51% -$6.5M ﹤0.01% 3089
2019
Q1
$17.7M Buy
868,516
+543,516
+167% +$11.1M ﹤0.01% 2562
2018
Q4
$4.96M Buy
+325,000
New +$4.96M ﹤0.01% 3090